{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:58:40Z","timestamp":1791367120518,"version":"4.3.1"},"reference-count":288,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010007","name":"Chinesisch-Deutsche Zentrum f\u00fcr Wissenschaftsf\u00f6rderung","doi-asserted-by":"publisher","award":["GZ919"],"award-info":[{"award-number":["GZ919"]}],"id":[{"id":"10.13039\/501100010007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025294","name":"Research Ireland","doi-asserted-by":"publisher","award":["21\/RC\/10294_P2"],"award-info":[{"award-number":["21\/RC\/10294_P2"]}],"id":[{"id":"10.13039\/501100025294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025YFHZ0121"],"award-info":[{"award-number":["2025YFHZ0121"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024JDHJ0043"],"award-info":[{"award-number":["2024JDHJ0043"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024JDHJ0043,2025YFHZ0121"],"award-info":[{"award-number":["2024JDHJ0043,2025YFHZ0121"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107989","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:56:50Z","timestamp":1759993010000},"page":"107989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Purinergic modulation of major depressive disorder: Experimental findings, pathogenesis and therapeutic opportunities"],"prefix":"10.1016","volume":"221","author":[{"given":"Xing-Ying","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Rubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9137-0637","authenticated-orcid":false,"given":"Tobias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-066X","authenticated-orcid":false,"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-9389","authenticated-orcid":false,"given":"Peter","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107989_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112778","article-title":"P2X7 receptor signaling in stress and depression","volume":"20","author":"Ribeiro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2174\/1570159X20666220302152400","article-title":"A possible causal involvement of neuroinflammatory, purinergic P2X7 receptors in psychiatric disorders","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109252","article-title":"Astrocytes and major depression: the purinergic avenue","volume":"220","author":"Zhao","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu14132751","article-title":"The efficacy of S-Adenosyl methionine and probiotic supplementation on depression: a synergistic approach","volume":"14","author":"Ullah","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107989_bib5","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from The National comorbidity survey replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2025.107989_bib6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2025.107989_bib7","first-page":"4","article-title":"Mechanism of action of antidepressant medications","volume":"60","author":"Feighner","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/0929867013373796","article-title":"Current trends in the development of new antidepressants","volume":"8","author":"Pacher","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fphar.2018.00526","article-title":"Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression","volume":"9","author":"L\u00f3pez-Cruz","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1745017901309010142","article-title":"Which drug for which patient? Is there a fluoxetine responding versus a bupropion responding personality profile?","volume":"9","author":"Bell","year":"2013","journal-title":"Clin. Pract. Epidemiol. Ment. Health CP EMH"},{"key":"10.1016\/j.phrs.2025.107989_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eurpsy.2017.07.003","article-title":"Clinical relevance of findings in trials of CBT for depression","volume":"45","author":"Lepping","year":"2017","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.phrs.2025.107989_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11920-022-01326-3","article-title":"Moderators of cognitive behavioral treatment for insomnia on depression and anxiety outcomes","volume":"24","author":"Mirchandaney","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.phrs.2025.107989_bib14","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1007\/s12035-023-03810-0","article-title":"Microglia as a game changer in epilepsy comorbid depression","volume":"61","author":"Wen","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ynstr.2017.03.003","article-title":"Animal models in psychiatric research: the RDoC system as a new framework for endophenotype-oriented translational neuroscience","volume":"7","author":"Anderzhanova","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2025.107989_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ynstr.2016.10.001","article-title":"Chronic psychosocial stressors in adulthood: studies in mice, rats and tree shrews","volume":"6","author":"Pryce","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2025.107989_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib19","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2174\/1570159X20666220302152400","article-title":"A possible causal involvement of neuroinflammatory, purinergic P2X7 receptors in psychiatric disorders","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s12264-020-00602-7","article-title":"Purinergic signaling in the central nervous system in health and disease","volume":"36","author":"Illes","year":"2020","journal-title":"Neurosci. Bull."},{"issue":"2020","key":"10.1016\/j.phrs.2025.107989_bib22","article-title":"Dysregulation of astrocytic ATP\/Adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy","volume":"6","author":"Illes","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.phrs.2025.107989_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: an overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bies.201100130","article-title":"Purinergic signalling: its unpopular beginning, its acceptance and its exciting future","volume":"34","author":"Burnstock","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.phrs.2025.107989_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","article-title":"Purinergic signalling: from discovery to current developments","volume":"99","author":"Burnstock","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107989_bib29","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1073\/pnas.1120997109","article-title":"Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity","volume":"109","author":"Lovatt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2025.107989_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smrv.2010.06.005","article-title":"Adenosine, energy metabolism and sleep homeostasis","volume":"15","author":"Porkka-Heiskanen","year":"2011","journal-title":"Sleep. Med. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib31","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1523\/JNEUROSCI.21-07-02298.2001","article-title":"A depletable pool of adenosine in area CA1 of the rat hippocampus","volume":"21","author":"Pearson","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib32","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/acschemneuro.2c00810","article-title":"Increased synaptic ATP release and CD73-Mediated formation of extracellular adenosine in the control of behavioral and electrophysiological modifications caused by chronic stress","volume":"14","author":"Dias","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.672182","article-title":"Metabolic aspects of adenosine functions in the brain","volume":"12","author":"Garcia-Gil","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107011","article-title":"The P2X7 receptor in depression: novel insights and therapeutic implications","volume":"213","author":"Zhong","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2025.107989_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psyneuen.2018.08.015","article-title":"Emerging role of the P2X7-NLRP3-IL1\u03b2 pathway in mood disorders","volume":"98","author":"Bhattacharya","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2025.107989_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fnmol.2020.00124","article-title":"The P2X7 receptor: central hub of brain diseases","volume":"13","author":"Andrejew","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib37","article-title":"The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib38","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1007\/s12035-022-03001-3","article-title":"A pattern to link adenosine signaling, circadian system, and potential final common pathway in the pathogenesis of major depressive disorder","volume":"59","author":"Wang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/157015909789152191","article-title":"Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition","volume":"7","author":"Shen","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2024.04.013","article-title":"Extracellular ATP is a homeostatic messenger that mediates Cell-Cell communication in physiological processes and psychiatric diseases","volume":"97","author":"Chen","year":"2025","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib41","first-page":"7","article-title":"The fifth heymans memorial lecture-Ghent, February 17, 1990. Co-transmission","volume":"304","author":"Burnstock","year":"1990","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002100000311","article-title":"Neuronal P2X receptors: localisation and functional properties, Naunyn-Schmiedeberg's","volume":"362","author":"N\u00f6renberg","year":"2000","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.1994.sp020176","article-title":"ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings","volume":"477","author":"Redman","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2009.12.002","article-title":"Vas deferens--a model used to establish sympathetic cotransmission","volume":"31","author":"Burnstock","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib45","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/0024-3205(84)90470-3","article-title":"A pharmacological investigation of the biphasic nature of the contractile response of rabbit and rat vas deferens to field stimulation","volume":"35","author":"Sneddon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib46","first-page":"365","article-title":"Noradrenaline and ATP: cotransmitters and neuromodulators","volume":"46","author":"Burnstock","year":"1995","journal-title":"J. Physiol. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/359144a0","article-title":"ATP receptor-mediated synaptic currents in the central nervous system","volume":"359","author":"Edwards","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107989_bib48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1152\/jn.1994.71.3.868","article-title":"ATP-induced inward current in neurons freshly dissociated from the tuberomammillary nucleus","volume":"71","author":"Furukawa","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.phrs.2025.107989_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjp.0701386","article-title":"Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat","volume":"122","author":"Nieber","year":"1997","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.tins.2021.07.004","article-title":"Astrocyte and neuron cooperation in long-term depression","volume":"44","author":"Durkee","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ncb1620","article-title":"Regulated ATP release from astrocytes through lysosome exocytosis","volume":"9","author":"Zhang","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107989_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.15252\/embj.201592705","article-title":"Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion","volume":"35","author":"Verkhratsky","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2025.107989_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnmol.2019.00023","article-title":"Connexin hemichannels in astrocytes: role in CNS disorders","volume":"12","author":"Xing","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11302-007-9077-8","article-title":"Oxygen-glucose deprivation induces ATP release via maxi-anion channels in astrocytes","volume":"4","author":"Liu","year":"2008","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib55","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.tins.2019.09.006","article-title":"Astroglia-Derived ATP modulates CNS neuronal circuits","volume":"42","author":"Illes","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2018.12.021","article-title":"Microglia and the purinergic signaling system","volume":"405","author":"Calovi","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107989_bib57","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/cr.2012.10","article-title":"Microglial migration mediated by ATP-induced ATP release from lysosomes","volume":"22","author":"Dou","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2025.107989_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ebiom.2018.05.036","article-title":"Anti-Depressant fluoxetine reveals its therapeutic effect via astrocytes","volume":"32","author":"Kinoshita","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.107989_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110209","article-title":"Adenosine regulates depressive behavior in mice with chronic social defeat stress through gut microbiota","volume":"262","author":"Huang","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnmol.2019.00331","article-title":"Pathological ATPergic signaling in major depression and bipolar disorder","volume":"12","author":"Illes","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nm.3162","article-title":"Astrocyte-derived ATP modulates depressive-like behaviors","volume":"19","author":"Cao","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41398-021-01631-0","article-title":"APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline","volume":"11","author":"Fang","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib63","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12264-021-00726-4","article-title":"The ATP level in the mPFC mediates the antidepressant effect of calorie restriction","volume":"37","author":"Wang","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.phrs.2025.107989_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116850","article-title":"Prophylactic nicotinamide mononucleotide (NMN) mitigates CSDS-induced depressive-like behaviors in mice via preserving of ATP level in the mPFC","volume":"176","author":"Deng","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib65","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1111\/ejn.14969","article-title":"The effects of microglia- and astrocyte-derived factors on neurogenesis in health and disease","volume":"54","author":"Araki","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib66","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1074\/jbc.M209454200","article-title":"Storage and release of ATP from astrocytes in culture","volume":"278","author":"Coco","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib67","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1042\/BST20140163","article-title":"Exocytosis of gliotransmitters from cortical astrocytes: implications for synaptic plasticity and aging","volume":"42","author":"Lalo","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2025.107989_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphar.2012.00139","article-title":"Calcium signaling and gliotransmission in normal vs. Reactive astrocytes","volume":"3","author":"Agulhon","year":"2012","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2022.02.014","article-title":"The ATP level in the medial prefrontal cortex regulates Depressive-like behavior via the medial prefrontal Cortex-Lateral habenula pathway","volume":"92","author":"Lin","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib70","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.7150\/thno.72144","article-title":"P2X2 receptors in pyramidal neurons are critical for regulating vulnerability to chronic stress","volume":"12","author":"Kuang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2025.107989_bib71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ebiom.2018.05.036","article-title":"Anti-Depressant fluoxetine reveals its therapeutic effect via astrocytes","volume":"32","author":"Kinoshita","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.107989_bib72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41380-024-02692-5","article-title":"Deletion of murine astrocytic vesicular nucleotide transporter increases anxiety and depressive-like behavior and attenuates motivation for reward","volume":"30","author":"Huang","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib73","article-title":"Glial purinergic signals and psychiatric disorders","volume":"15","author":"Koizumi","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","article-title":"Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior","volume":"72","author":"Halassa","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib75","article-title":"Lysosomal TFEB-TRPML1 axis in astrocytes modulates Depressive-like behaviors","volume":"11","author":"Mo","year":"2024","journal-title":"Advanced science (Weinheim BadenWurttemberg Germany)"},{"key":"10.1016\/j.phrs.2025.107989_bib76","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1523\/JNEUROSCI.1216-11.2012","article-title":"Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury","volume":"32","author":"Huang","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib77","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/glia.22695","article-title":"Mechanosensitive release of adenosine 5\u2032-triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: a mechanism for purinergic involvement in chronic strain","volume":"62","author":"Beckel","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107989_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.06.045","article-title":"Connexin-based intercellular communication and astrocyte heterogeneity","volume":"1487","author":"Theis","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107989_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.00042.2016","article-title":"Physiology of astroglia","volume":"98","author":"Verkhratsky","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib80","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41401-022-00861-2","article-title":"Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2025.107989_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2017.12.003","article-title":"Corticosterone impairs gap junctions in the prefrontal cortical and hippocampal astrocytes via different mechanisms","volume":"131","author":"Xia","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107798","article-title":"Astrocytic connexin43 in the medial prefrontal cortex regulates depressive- and anxiety-like behaviors via ATP release","volume":"217","author":"Wang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib83","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2017.12.004","article-title":"Pannexin-1 channel dysfunction in the medial prefrontal cortex mediates depressive-like behaviors induced by chronic social defeat stress and administration of mefloquine in mice","volume":"137","author":"Ni","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib84","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/mp.2017.229","article-title":"Z. Yuan, Calhm2 governs astrocytic ATP releasing in the development of depression-like behaviors","volume":"23","author":"Ma","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib85","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s11010-021-04198-y","article-title":"Human CALHM5: insight in large pore lipid gating ATP channel and associated neurological pathologies","volume":"476","author":"Bhat","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2025.107989_bib86","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1002\/alz.13366","article-title":"CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and alzheimer's disease risk","volume":"19","author":"Liao","year":"2023","journal-title":"Alzheimer's. Dement. J. Alzheimer's. Assoc."},{"key":"10.1016\/j.phrs.2025.107989_bib87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2021.11.022","article-title":"Glucocorticoid Receptor-Dependent astrocytes mediate stress vulnerability","volume":"92","author":"Lu","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib88","article-title":"Genetic and pharmacological inhibition of astrocytic Mysm1 alleviates Depressive-Like disorders by promoting ATP production","volume":"10","author":"Zhang","year":"2022","journal-title":"Advanced science (Weinheim BadenWurttemberg Germany)"},{"key":"10.1016\/j.phrs.2025.107989_bib89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib90","article-title":"Extracellular ATP\/adenosine dynamics in the brain and its role in health and disease","volume":"11","author":"Shigetomi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2025.107989_bib91","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/s41380-024-02851-8","article-title":"Astrocytes release ATP\/ADP and glutamate in flashes via vesicular exocytosis","volume":"30","author":"Li","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030160","article-title":"Purinergic signaling and related biomarkers in depression","volume":"10","author":"Bartoli","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib93","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949921","article-title":"Depression: a new enzyme AT play","volume":"21","author":"Martins","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2025.107989_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115152","article-title":"Overexpressed CD73 attenuates GSDMD-mediated astrocyte pyroptosis induced by cerebral ischemia-reperfusion injury through the A2B\/NF-\u03baB pathway","volume":"386","author":"Zhuang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107989_bib95","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib96","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947857","article-title":"Hippocampal CD39\/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP","volume":"21","author":"Cui","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2025.107989_bib97","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbi.2024.01.012","article-title":"Glia-derived adenosine in the ventral hippocampus drives pain-related anxiodepression in a mouse model resembling trigeminal neuralgia","volume":"117","author":"Lv","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib98","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","article-title":"Negative feedback control of neuronal activity by microglia","volume":"586","author":"Badimon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107989_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2018.06.048","article-title":"Early-life hyperthermic seizures upregulate adenosine A(2A) receptors in the cortex and promote depressive-like behavior in adult rats","volume":"86","author":"Crespo","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.phrs.2025.107989_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103005","article-title":"Enhancing HIF-1\u03b1-P2X2 signaling in dorsal raphe serotonergic neurons promotes psychological resilience","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2025.107989_bib101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2022.11.042","article-title":"Association of adenosine triphosphate-related genes to major depression and suicidal behavior: cognition as a potential mediator","volume":"323","author":"Zheng","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.107989_bib102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2015.10.032","article-title":"Purinergic receptors in psychiatric disorders","volume":"104","author":"Kr\u00fcgel","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.02.023","article-title":"P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT","volume":"493","author":"Viikki","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107989_bib104","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1007\/s12035-022-03023-x","article-title":"Pinocembrin inhibits P2X4 Receptor-Mediated pyroptosis in hippocampus to alleviate the behaviours of chronic pain and depression comorbidity in rats","volume":"59","author":"Yang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib105","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1021\/acschemneuro.0c00623","article-title":"Contribution of the P2X4 receptor in rat hippocampus to the comorbidity of chronic pain and depression","volume":"11","author":"Li","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jad.2024.07.052","article-title":"The role of P2X4R in regulating CA1 hippocampal synaptic impairment in LPS-induced depression","volume":"362","author":"Wei","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.107989_bib107","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib108","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S1461145712000909","article-title":"Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin","volume":"16","author":"Bortolato","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib109","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7834","article-title":"Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model","volume":"7","author":"Ribeiro","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2025.107989_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbi.2017.07.155","article-title":"Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke","volume":"66","author":"Verma","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/14728222.2023.2258281","article-title":"The neuroinflammatory astrocytic P2X7 receptor: alzheimer's disease, ischemic brain injury, and epileptic state","volume":"27","author":"Ahn","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phrs.2025.107989_bib112","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.3103-16.2017","article-title":"Neuronal P2X7 receptors revisited: do they really exist?","volume":"37","author":"Illes","year":"2017","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2024.05.023","article-title":"Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in Male mice","volume":"120","author":"Alves","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115959","article-title":"Purinergic P2X7 receptor as a potential therapeutic target in depression","volume":"219","author":"Qi","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/0929867329666220629141418","article-title":"Recent advances in the development of antidepressants targeting the purinergic P2X7 receptor","volume":"30","author":"Lee","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106625","article-title":"The NLRP3 inflammasome in depression: potential mechanisms and therapies","volume":"187","author":"Xia","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib117","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146852","article-title":"NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2025.107989_bib118","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbi.2024.12.023","article-title":"Demyelination of the amygdala mediates psychological stress-induced emotional disorders partially contributed by activation of P2X7R\/NLRP3 cascade","volume":"124","author":"Li","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","article-title":"Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors","volume":"14","author":"Yue","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.107989_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110432","article-title":"Tabersonine ameliorates depressive-like behavior by inhibiting NLRP3 inflammasome activation in a mouse model","volume":"273","author":"Shi","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","article-title":"NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder","volume":"36","author":"Alcocer-G\u00f3mez","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130624","article-title":"NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes","volume":"10","author":"Gustin","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107989_bib123","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.immuni.2024.01.018","article-title":"Disruption of the Na+\/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety","volume":"57","author":"Huang","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.107989_bib124","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1093\/cercor\/bhad166","article-title":"P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex","volume":"33","author":"Ren","year":"2023","journal-title":"Cereb. cortex (N. Y. N. Y. 1991)"},{"key":"10.1016\/j.phrs.2025.107989_bib125","article-title":"Total paeony glycoside relieves neuroinflammation to exert antidepressant effect via the interplay between NLRP3 inflammasome, pyroptosis and autophagy","volume":"128","author":"Su","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.phrs.2025.107989_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136290","article-title":"Inhibition of the NLRP3 inflammasome with MCC950 prevents chronic social isolation-induced depression-like behavior in Male mice","volume":"765","author":"Li","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107989_bib127","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-025-10074-x","article-title":"Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line","author":"von M\u00fccke-Heim","year":"2025","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.01.018","article-title":"NLRP3 gene knockout blocks NF-\u03baB and MAPK signaling pathway in CUMS-induced depression mouse model","volume":"322","author":"Su","year":"2017","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.phrs.2025.107989_bib129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","article-title":"Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2\u00d77 receptor","volume":"80","author":"Iwata","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00406-021-01306-3","article-title":"P2X7R antagonists in chronic stress-based depression models: a review","volume":"271","author":"von Muecke-Heim","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib131","article-title":"Microglia-Derived Interleukin-6 triggers astrocyte apoptosis in the hippocampus and mediates Depression-Like behavior","volume":"12","author":"Shen","year":"2025","journal-title":"Advanced science (Weinheim BadenWurttemberg Germany)"},{"key":"10.1016\/j.phrs.2025.107989_bib132","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers - a meta-analysis","volume":"80","author":"Wi\u0119d\u0142ocha","year":"2018","journal-title":"Prog. neuroPsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2018.11.022","article-title":"Ketamine May exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors","volume":"146","author":"Li","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib134","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jare.2024.07.015","article-title":"Hyperibone j exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R\/TLR4-mediated neuroinflammation","volume":"72","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib135","article-title":"Saikosaponins from bupleurum scorzonerifolium willd. Alleviates microglial pyroptosis in depression by binding and inhibiting P2X7 expression","volume":"136","author":"Bi","year":"2025","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.phrs.2025.107989_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.812362","article-title":"Salidroside ameliorates depression by suppressing NLRP3-Mediated pyroptosis via P2X7\/NF-\u03baB\/NLRP3 signaling pathway","volume":"13","author":"Chai","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib137","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02117-z","article-title":"Arctiin mitigates neuronal injury by modulating the P2X7R\/NLPR3 inflammasome signaling pathway","author":"Jin","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2025.107989_bib138","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/jpet.104.066712","article-title":"P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices","volume":"310","author":"Papp","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib139","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/00001756-200410250-00017","article-title":"Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-\/- mice","volume":"15","author":"Papp","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2025.107989_bib140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(02)00029-0","article-title":"Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors","volume":"320","author":"Fujino","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107989_bib141","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1471-4159.1988.tb02462.x","article-title":"Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress","volume":"50","author":"Adell","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107989_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107989_bib143","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnmol.2017.00325","article-title":"Regulation of hippocampal 5-HT release by P2X7 receptors in response to optogenetic stimulation of median raphe terminals of mice","volume":"10","author":"G\u00f6l\u00f6ncs\u00e9r","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib144","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.euroneuro.2013.01.008","article-title":"Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide","volume":"23","author":"Pereira","year":"2013","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175389","article-title":"Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia","volume":"938","author":"Chisari","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib146","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12264-020-00524-4","article-title":"Sleep deprivation selectively Down-Regulates astrocytic 5-HT2B receptors and triggers Depressive-Like behaviors via stimulating P2X7 receptors in mice","volume":"36","author":"Xia","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.phrs.2025.107989_bib147","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11302-022-09879-x","article-title":"Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions","volume":"19","author":"Sun","year":"2023","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib148","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0269881119872173","article-title":"Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation","volume":"33","author":"Ribeiro","year":"2019","journal-title":"J. Psychopharmacol. (Oxf. Engl. )"},{"key":"10.1016\/j.phrs.2025.107989_bib149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","article-title":"The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice","volume":"16","author":"Cs\u00f6lle","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.euroneuro.2025.03.004","article-title":"Exploring the prospective association of serum interleukin-1\u03b2 and brain-derived neurotrophic factor with antidepressant treatment response","volume":"95","author":"Cho","year":"2025","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib151","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pnpbp.2019.01.006","article-title":"Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms","volume":"92","author":"Vereczkei","year":"2019","journal-title":"Prog. neuroPsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib152","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pnpbp.2017.11.003","article-title":"The P2RX7 polymorphism rs2230912 is associated with depression: a meta-analysis","volume":"82","author":"Czamara","year":"2018","journal-title":"Prog. neuroPsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib153","article-title":"Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: a meta-analysis","volume":"9","author":"Feng","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107989_bib154","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.molmed.2018.07.005","article-title":"P2X7 receptor: a potential therapeutic target for depression?","volume":"24","author":"Deussing","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114361","article-title":"Molecular pharmacology of P2Y receptor subtypes","volume":"187","author":"von K\u00fcgelgen","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib156","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11302-021-09827-1","article-title":"Involvement of purinergic P2Y1R in antidepressant-like effects of electroacupuncture treatment on social isolation stress mice","volume":"19","author":"Yu","year":"2023","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib157","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbi.2025.04.010","article-title":"Stimulation of microglia leads to a rapid antidepressant effect by triggering astrocytic P2Y1Rs and promoting BDNF-mediated neurogenesis in the hippocampus","volume":"128","author":"Wang","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107989_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051108","article-title":"Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS","volume":"9","author":"Illes","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107989_bib159","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13020-021-00553-9","article-title":"P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease","volume":"16","author":"Li","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib160","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41386-022-01519-7","article-title":"Microglial P2Y12 mediates chronic stress-induced synapse loss in the prefrontal cortex and associated behavioral consequences","volume":"48","author":"Bollinger","year":"2023","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib161","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2021-100529","article-title":"CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation","volume":"34","author":"Wu","year":"2021","journal-title":"Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib162","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5197626","article-title":"Equilibrative nucleoside transporter 2: properties and physiological roles","volume":"2020","author":"Naes","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phrs.2025.107989_bib163","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fphar.2018.00606","article-title":"Emerging roles of nucleoside transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.703783","article-title":"Inosine as a tool to understand and treat central nervous system disorders: a neglected actor?","volume":"15","author":"Nascimento","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/WNR.0000000000001101","article-title":"Inosine alleviates depression-like behavior and increases the activity of the ERK-CREB signaling in adolescent Male rats","volume":"29","author":"Yuan","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2025.107989_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105363","article-title":"Of adenosine and the blues: the adenosinergic system in the pathophysiology and treatment of major depressive disorder","volume":"163","author":"Gomes","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib167","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1074\/jbc.M111.291666","article-title":"AMP is an adenosine A1 receptor agonist","volume":"287","author":"Rittiner","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"S4","key":"10.1016\/j.phrs.2025.107989_bib168","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6105.S4-004","article-title":"D.-S. Choi, Sex-Specific regulation of depression, Anxiety-Like behaviors and alcohol drinking in mice lacking ENT1","author":"L. Ruby","year":"2011","journal-title":"J. Addict. Res. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib169","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11302-013-9361-8","article-title":"The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and a 2A receptors","volume":"9","author":"Kaster","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11302-016-9551-2","article-title":"Signaling pathways underlying the antidepressant-like effect of inosine in mice","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib171","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1038\/srep04199","article-title":"Oral administration of inosine produces antidepressant-like effects in mice","volume":"4","author":"Muto","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107989_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. Lxxxi. nomenclature and classification of adenosine receptors--an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib173","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/pharmrev.121.000445","article-title":"International union of basic and clinical pharmacology. Cxii: adenosine receptors: a further update","volume":"74","author":"IJzerman","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib174","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.phrs.2025.107989_bib175","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1523\/JNEUROSCI.17-13-04956.1997","article-title":"Adenosine A1 receptor-mediated activation of phospholipase c in cultured astrocytes depends on the level of receptor expression","volume":"17","author":"Biber","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib176","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cns.13190","article-title":"Research progress on adenosine in central nervous system diseases","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib177","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(25)06782-1","article-title":"Nomenclature and classification of purinoceptors","volume":"46","author":"Fredholm","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib178","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.neuron.2014.02.007","article-title":"Gliotransmitters travel in time and space","volume":"81","author":"Araque","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107989_bib179","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","article-title":"The tripartite synapse: roles for gliotransmission in health and disease","volume":"13","author":"Halassa","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1116916","article-title":"Astrocytic purinergic signaling coordinates synaptic networks","volume":"310","author":"Pascual","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107989_bib181","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuron.2008.11.024","article-title":"Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss","volume":"61","author":"Halassa","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107989_bib182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/glia.22422","article-title":"The importance of astrocyte-derived purines in the modulation of sleep","volume":"61","author":"Blutstein","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107989_bib183","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jaci.2005.08.005","article-title":"Links between the innate immune system and sleep","volume":"116","author":"Majde","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2025.107989_bib184","doi-asserted-by":"crossref","first-page":"R947","DOI":"10.1152\/ajpregu.2000.278.4.R947","article-title":"Dose-dependent effects of endotoxin on human sleep","volume":"278","author":"Mullington","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib185","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/glia.22465","article-title":"Astrocyte-derived adenosine modulates increased sleep pressure during inflammatory response","volume":"61","author":"Nadjar","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107989_bib186","doi-asserted-by":"crossref","first-page":"16594","DOI":"10.1523\/JNEUROSCI.2585-14.2014","article-title":"Neuronal transgene expression in dominant-negative SNARE mice","volume":"34","author":"Fujita","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib187","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/s41467-024-50466-y","article-title":"Adenosine triggers early astrocyte reactivity that provokes microglial responses and drives the pathogenesis of sepsis-associated encephalopathy in mice","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107989_bib188","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2003.10.040","article-title":"Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors","volume":"355","author":"Kaster","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107989_bib189","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.136","article-title":"Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling","volume":"3","author":"Hines","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2015.07.010","article-title":"Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit Depressive-like behavior via induction of Homer1a","volume":"87","author":"Serchov","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107989_bib191","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1037\/0735-7044.108.2.265","article-title":"Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats","volume":"108","author":"Minor","year":"1994","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib192","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1523\/JNEUROSCI.2181-06.2006","article-title":"Adenosine and sleep homeostasis in the basal forebrain","volume":"26","author":"Blanco-Centurion","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib193","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.neuroscience.2007.03.009","article-title":"Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness","volume":"146","author":"McKenna","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107989_bib194","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/jcr.171","article-title":"Intracerebral adenosine during sleep deprivation: a Meta-Analysis and new experimental data","volume":"16","author":"Leenaars","year":"2018","journal-title":"J. Circadian Rhythms"},{"key":"10.1016\/j.phrs.2025.107989_bib195","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.276.5316.1265","article-title":"Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness","volume":"276","author":"Porkka-Heiskanen","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107989_bib196","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2008.12.056","article-title":"Sleep deprivation increases A(1) adenosine receptor density in the rat brain","volume":"1258","author":"Elmenhorst","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107989_bib197","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1073\/pnas.1614677114","article-title":"Recovery sleep after extended wakefulness restores elevated A(1) adenosine receptor availability in the human brain","volume":"114","author":"Elmenhorst","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2025.107989_bib198","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.14841","article-title":"The role of adenosine receptors in mood and anxiety disorders","volume":"151","author":"van Calker","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107989_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107834","article-title":"Enhanced adenosine A(1) receptor and Homer1a expression in hippocampus modulates the resilience to stress-induced depression-like behavior","volume":"162","author":"Serchov","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(84)90670-X","article-title":"The effects of chronic lithium and ECT on A1 and A2 adenosine receptor systems in rat brain","volume":"291","author":"Newman","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107989_bib201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2015.08.046","article-title":"Adenosinergic signaling in epilepsy","volume":"104","author":"Boison","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib202","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1228438","article-title":"Effects of electroconvulsive therapy on cerebral A(1) adenosine receptor availability: a PET study in patients suffering from treatment-resistant major depressive disorder","volume":"14","author":"Kroll","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s40001-024-02028-7","article-title":"A(2A)R regulate inflammation through PKA\/NF-\u03baB signaling pathways in intervertebral disc degeneration","volume":"29","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104338","article-title":"Adenosine A(2A) receptor as potential therapeutic target in neuropsychiatric disorders","volume":"147","author":"Domenici","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib205","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and parkinson's disease","volume":"61","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107989_bib206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/caff.2018.0017","article-title":"New developments on the adenosine mechanisms of the central effects of caffeine and their implications for neuropsychiatric disorders","volume":"8","author":"Ferr\u00e9","year":"2018","journal-title":"J. Caffeine Aden Res."},{"key":"10.1016\/j.phrs.2025.107989_bib207","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in parkinson disease--epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2025.107989_bib208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjp.0704240","article-title":"Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice","volume":"134","author":"Yacoubi","year":"2001","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib209","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000095220.87550.F6","article-title":"Adenosine A2A receptors and depression","volume":"61","author":"El Yacoubi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107989_bib210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12640-018-9959-2","article-title":"Antidepressant-Like activity of typical antidepressant drugs in the forced swim test and tail suspension test in mice is augmented by DMPX, an adenosine A(2A) receptor antagonist","volume":"35","author":"Poleszak","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib211","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","article-title":"Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents","volume":"114-115","author":"Yamada","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2025.107989_bib212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fpsyt.2014.00067","article-title":"Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety","volume":"5","author":"Coelho","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib213","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41467-023-37601-x","article-title":"Lateral septum adenosine A(2A) receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107989_bib214","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11302-023-09946-x","article-title":"Adenosine A2A receptor-bearing GABAergic neurons in the lateral septum of the brain: novel mediators of depressive-like behavior","volume":"20","author":"Zhao","year":"2024","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib215","article-title":"Brain specific RagA overexpression triggers Depressive-Like behaviors in mice via activating ADORA2A signaling pathway","volume":"11","author":"Zhao","year":"2024","journal-title":"Advanced science (Weinheim BadenWurttemberg Germany)"},{"key":"10.1016\/j.phrs.2025.107989_bib216","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.molcel.2017.10.016","article-title":"Hybrid structure of the RagA\/C-Ragulator mTORC1 activation complex","volume":"68","author":"Su","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.107989_bib217","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1007\/s12035-015-9270-7","article-title":"Unpredictable chronic stress alters adenosine metabolism in zebrafish brain","volume":"53","author":"Zimmermann","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physbeh.2012.11.001","article-title":"The effect of unpredictable chronic mild stress on depressive-like behavior and on hippocampal A1 and striatal A2A adenosine receptors","volume":"109","author":"Crema","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2025.107989_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.952","article-title":"Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy","volume":"8","author":"Padilla","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.phrs.2025.107989_bib220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2025.107989_bib221","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1590\/1516-4446-2013-1098","article-title":"Animal models as tools to study the pathophysiology of depression","volume":"35","author":"Abelaira","year":"2013","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib222","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib223","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib224","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: a beginner's guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib225","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16299","article-title":"Impact of Glucocorticoid-Associated Stress-Like conditions on Aquaporin-4 in cultured astrocytes and its modulation by adenosine A(2A) receptors","volume":"169","author":"Dias","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107989_bib226","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The parkinson's complex: parkinsonism is just the tip of the iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107989_bib227","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2011.05.006","article-title":"The importance of non-motor disturbances to quality of life in parkinson's disease","volume":"310","author":"Martinez-Martin","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib228","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of parkinson's disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib229","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2018.11.005","article-title":"Effect of istradefylline on mood disorders in parkinson's disease","volume":"396","author":"Nagayama","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107989_bib230","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2020.09.022","article-title":"Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in parkinson's disease?","volume":"80","author":"Jenner","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.phrs.2025.107989_bib231","article-title":"Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib232","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib233","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41398-023-02557-5","article-title":"Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder","volume":"13","author":"Recourt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib234","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/acs.jmedchem.7b00408","article-title":"4-Methyl-6,7-dihydro-4H-triazolo4,5-cpyridine-Based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate","volume":"60","author":"Letavic","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib235","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol. (Oxf. Engl. )"},{"key":"10.1016\/j.phrs.2025.107989_bib236","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acs.jmedchem.7b01279","article-title":"A dipolar cycloaddition reaction to access 6-Methyl-4,5,6,7-tetrahydro-1H-1,2,3triazolo4,5-cpyridines enables the discovery synthesis and preclinical profiling of a P2X7 antagonist clinical candidate","volume":"61","author":"Chrovian","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib237","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"L.A.J. O\u2032neill, a small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111405","article-title":"NLRP3 in the dorsal raphe nucleus manipulates the depressive-like behaviors","volume":"227","author":"Cai","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2025.107989_bib239","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib240","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1176\/ajp.135.8.963","article-title":"J.F. Greden, P. Fontaine, M. Lubetsky, K. Chamberlin, anxiety and depression associated with caffeinism among psychiatric inpatients","volume":"135","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib241","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.150.2.294","article-title":"Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients","volume":"150","author":"Leibenluft","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib242","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hup.991","article-title":"Caffeine, cognitive failures and health in a non-working community sample","volume":"24","author":"Smith","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib243","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinternmed.2011.393","article-title":"Ascherio, coffee, caffeine, and risk of depression among women","volume":"171","author":"Lucas","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2025.107989_bib244","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","article-title":"Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress","volume":"112","author":"Kaster","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2025.107989_bib245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2015.02.032","article-title":"Adenosine signaling in reserpine-induced depression in rats","volume":"286","author":"Minor","year":"2015","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.phrs.2025.107989_bib246","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib247","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/1389203715666140901103205","article-title":"Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment","volume":"15","author":"Beggiato","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.phrs.2025.107989_bib248","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1080\/1028415X.2021.1906393","article-title":"Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF","volume":"25","author":"Basu Mallik","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib249","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pbb.2014.06.005","article-title":"Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice","volume":"124","author":"Kale","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2025.107989_bib250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00210-015-1189-z","article-title":"Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice, Naunyn-Schmiedeberg's","volume":"389","author":"Szopa","year":"2016","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114671","article-title":"Hippocampal and gut AMPK activation attenuates enterocolitis-like symptoms and co-occurring depressive-like behavior in ulcerative colitis model mice: involvement of brain-gut autophagy","volume":"373","author":"Takahashi","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107989_bib252","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib253","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate JR","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib254","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1038\/s41380-021-01246-3","article-title":"Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors","volume":"26","author":"Lazarevic","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib255","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s43440-024-00627-z","article-title":"Antidepressant effects of selective adenosine receptor antagonists targeting the A1 and A2A receptors administered jointly with NMDA receptor ligands: behavioral, biochemical and molecular investigations in mice","volume":"76","author":"Szopa","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2025.107989_bib256","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1007\/s12035-023-03474-w","article-title":"Ketamine counteracts sevoflurane-induced depressive-like behavior and synaptic plasticity impairments through the adenosine A2A receptor\/ERK pathway in rats","volume":"60","author":"Yu","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib257","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ddr.21345","article-title":"S-Adenosyl methionine in the therapy of depression and other psychiatric disorders","volume":"77","author":"Karas Ku\u017eeli\u010dki","year":"2016","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib258","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1871527314666150821103825","article-title":"A comprehensive review on the efficacy of S-Adenosyl-L-methionine in major depressive disorder","volume":"15","author":"de Berardis","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2025.107989_bib259","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.eurpsy.2011.03.006","article-title":"Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder","volume":"27","author":"Levkovitz","year":"2012","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.phrs.2025.107989_bib260","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.euroneuro.2018.07.098","article-title":"Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial<sup","volume":"28","author":"Sarris","year":"2018","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib261","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-019-05358-1","article-title":"S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial","volume":"237","author":"Sarris","year":"2020","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.phrs.2025.107989_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105442","article-title":"S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT(1A) receptors","volume":"162","author":"Sales","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2025.107989_bib263","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.13m08591","article-title":"A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder","volume":"75","author":"Mischoulon","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib264","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2014.03.041","article-title":"S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response","volume":"164","author":"Sarris","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.107989_bib265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WNR.0b013e32800fefd7","article-title":"S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis","volume":"18","author":"Guidotti","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2025.107989_bib266","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fncel.2016.00089","article-title":"Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders","volume":"10","author":"Guidotti","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2025.107989_bib267","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092162","article-title":"Alterations of the composition and neurometabolic profile of human gut microbiota in major depressive disorder","volume":"10","author":"Kovtun","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2025.107989_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101943","article-title":"The gut microbiota in anxiety and depression - a systematic review","volume":"83","author":"Simpson","year":"2021","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib269","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1039\/D0FO00373E","article-title":"Lactobacillus casei improves depression-like behavior in chronic unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota","volume":"11","author":"Gu","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2025.107989_bib270","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.clnu.2018.04.010","article-title":"Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial","volume":"38","author":"Kazemi","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.phrs.2025.107989_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176939","article-title":"The protective effect of S-adenosylmethionine on chronic adolescent stress-induced depression-like behaviors by regulating gut microbiota","volume":"982","author":"Xu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107989_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113930","article-title":"Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression: a monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial","volume":"156","author":"Ullah","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107989_bib273","doi-asserted-by":"crossref","first-page":"17697","DOI":"10.1016\/S0021-9258(17)32497-3","article-title":"Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex","volume":"269","author":"Bokar","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107989_bib274","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s12035-022-02739-0","article-title":"N6-methyladenosine and neurological diseases","volume":"59","author":"Zhang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107989_bib275","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/mp.2011.45","article-title":"Depressive disorder moderates the effect of the FTO gene on body mass index","volume":"17","author":"Rivera","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib276","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuron.2018.07.009","article-title":"The role of m(6)A\/m-RNA methylation in stress response regulation","volume":"99","author":"Engel","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107989_bib277","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-physiol-020518-114259","article-title":"ATP-Gated P2X receptor channels: molecular insights into functional roles","volume":"81","author":"Schmid","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib278","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.107989_bib279","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11302-021-09801-x","article-title":"Purinergic signaling: a potential therapeutic target for depression and chronic pain","volume":"19","author":"Zou","year":"2023","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.phrs.2025.107989_bib280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1113\/jphysiol.2003.049114","article-title":"Crossing the pain barrier: P2 receptors as targets for novel analgesics","volume":"553","author":"Kennedy","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2025.107989_bib281","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2025.107989_bib282","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","article-title":"Pharmacology and structure of P2Y receptors","volume":"104","author":"von K\u00fcgelgen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109477","article-title":"ATP-mediated signalling in the central synapses","volume":"229","author":"Lalo","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107989_bib284","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s12640-022-00550-2","article-title":"Scrutinizing the therapeutic promise of purinergic receptors targeting depression","volume":"40","author":"Sikka","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2025.107989_bib285","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41398-020-00992-2","article-title":"Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression","volume":"10","author":"B\u00f6ttcher","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107989_bib286","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/01.wnl.0000297939.18236.ec","article-title":"Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease","volume":"70","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107989_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107821","article-title":"Purinergic transmission in depressive disorders","volume":"224","author":"Szopa","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2025.107989_bib288","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:37:24Z","timestamp":1778582244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":288,"alternative-id":["S1043661825004141"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107989","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic modulation of major depressive disorder: Experimental findings, pathogenesis and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107989"}}